<?xml version="1.0" encoding="UTF-8"?>
<p>Therefore, CEPI is planning to support animal model development/refinement and natural history studies that can serve as a basis for qualification of the model by regulatory agencies. It is aligning with the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) guidelines to accelerate the development of models and tools to avoid the use of animals where possible, reduce the number of animals used per experiment, minimize animal suffering, and improve welfare [
 <xref ref-type="bibr" rid="CR30">30</xref>]. CEPI is currently mapping existing efforts and funding for such work and will explore collaborations and co-funding mechanisms as appropriate to avoid duplication of efforts in this space. The WHO has developed target product profiles (TPPs) for many of the priority pathogens, and CEPI uses the WHO TPPs as guiding documents to make many of its decisions regarding the feasibility and intended use of funded vaccines [
 <xref ref-type="bibr" rid="CR31">31</xref>–
 <xref ref-type="bibr" rid="CR33">33</xref>].
</p>
